176 related articles for article (PubMed ID: 17116387)
1. The use of ANAM to assess the side-effect profiles and efficacy of medication.
Wilken JA; Sullivan CL; Lewandowski A; Kane RL
Arch Clin Neuropsychol; 2007 Feb; 22 Suppl 1():S127-33. PubMed ID: 17116387
[TBL] [Abstract][Full Text] [Related]
2. Identifying and monitoring cognitive deficits in clinical populations using Automated Neuropsychological Assessment Metrics (ANAM) tests.
Kane RL; Roebuck-Spencer T; Short P; Kabat M; Wilken J
Arch Clin Neuropsychol; 2007 Feb; 22 Suppl 1():S115-26. PubMed ID: 17101258
[TBL] [Abstract][Full Text] [Related]
3. Assessing change with the Automated Neuropsychological Assessment Metrics (ANAM): issues and challenges.
Roebuck-Spencer T; Sun W; Cernich AN; Farmer K; Bleiberg J
Arch Clin Neuropsychol; 2007 Feb; 22 Suppl 1():S79-87. PubMed ID: 17118623
[TBL] [Abstract][Full Text] [Related]
4. Use of computerized assessment to predict neuropsychological functioning and emotional distress in patients with systemic lupus erythematosus.
Roebuck-Spencer TM; Yarboro C; Nowak M; Takada K; Jacobs G; Lapteva L; Weickert T; Volpe B; Diamond B; Illei G; Bleiberg J
Arthritis Rheum; 2006 Jun; 55(3):434-41. PubMed ID: 16739211
[TBL] [Abstract][Full Text] [Related]
5. Automated Neuropsychological Assessment Metrics sports medicine battery.
Cernich A; Reeves D; Sun W; Bleiberg J
Arch Clin Neuropsychol; 2007 Feb; 22 Suppl 1():S101-14. PubMed ID: 17118625
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of the ANAM General Neuropsychological Screening Battery (ANAM GNS) for detecting neurocognitive impairment in a mixed clinical sample.
Woodhouse J; Heyanka DJ; Scott J; Vincent A; Roebuck-Spencer T; Domboski-Davidson K; O'Mahar K; Adams R
Clin Neuropsychol; 2013; 27(3):376-85. PubMed ID: 23368639
[TBL] [Abstract][Full Text] [Related]
7. Automated neuropsychological assessment metrics (ANAM) measures of cognitive effects of Alzheimer's disease.
Levinson D; Reeves D; Watson J; Harrison M
Arch Clin Neuropsychol; 2005 May; 20(3):403-8. PubMed ID: 15797175
[TBL] [Abstract][Full Text] [Related]
8. Retest reliability in adolescents of a computerized neuropsychological battery used to assess recovery from concussion.
Segalowitz SJ; Mahaney P; Santesso DL; MacGregor L; Dywan J; Willer B
NeuroRehabilitation; 2007; 22(3):243-51. PubMed ID: 17917174
[TBL] [Abstract][Full Text] [Related]
9. Computerized measurement of cognitive impairment and associated neuropsychiatric dimensions.
Gottschalk LA; Bechtel RJ; Maguire GA; Harrington DE; Levinson DM; Franklin DL; Carcamo D
Compr Psychiatry; 2000; 41(5):326-33. PubMed ID: 11011827
[TBL] [Abstract][Full Text] [Related]
10. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
11. [NeuroCogFX--a computer-based neuropsychological assessment battery for the follow-up examination of neurological patients].
Fliessbach K; Hoppe C; Schlegel U; Elger CE; Helmstaedter C
Fortschr Neurol Psychiatr; 2006 Nov; 74(11):643-50. PubMed ID: 17103364
[TBL] [Abstract][Full Text] [Related]
12. Factor analysis of computerized and traditional tests used in mild brain injury research.
Bleiberg J; Kane RL; Reeves DL; Garmoe WS; Halpern E
Clin Neuropsychol; 2000 Aug; 14(3):287-94. PubMed ID: 11262703
[TBL] [Abstract][Full Text] [Related]
13. Construct validity of selected Automated Neuropsychological Assessment Metrics (ANAM) battery measures.
Kabat MH; Kane RL; Jefferson AL; DiPino RK
Clin Neuropsychol; 2001 Dec; 15(4):498-507. PubMed ID: 11935451
[TBL] [Abstract][Full Text] [Related]
14. Initial construct validation of frequently employed ANAM measures through structural equation modeling.
Short P; Cernich A; Wilken JA; Kane RL
Arch Clin Neuropsychol; 2007 Feb; 22 Suppl 1():S63-77. PubMed ID: 17145163
[TBL] [Abstract][Full Text] [Related]
15. Cognitive testing in early-phase clinical trials: development of a rapid computerized test battery and application in a simulated Phase I study.
Collie A; Darekar A; Weissgerber G; Toh MK; Snyder PJ; Maruff P; Huggins JP
Contemp Clin Trials; 2007 Jul; 28(4):391-400. PubMed ID: 17267292
[TBL] [Abstract][Full Text] [Related]
16. The ARES test system for palm OS handheld computers.
Elsmore TF; Reeves DL; Reeves AN
Arch Clin Neuropsychol; 2007 Feb; 22 Suppl 1():S135-44. PubMed ID: 17166694
[TBL] [Abstract][Full Text] [Related]
17. Automated neuropsychological assessment metrics (ANAM) and Woodcock-Johnson III Tests of Cognitive Ability: a concurrent validity study.
Jones WP; Loe SA; Krach SK; Rager RY; Jones HM
Clin Neuropsychol; 2008 Mar; 22(2):305-20. PubMed ID: 17853133
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychological assessment in extreme environments.
Lowe M; Harris W; Kane RL; Banderet L; Levinson D; Reeves D
Arch Clin Neuropsychol; 2007 Feb; 22 Suppl 1():S89-99. PubMed ID: 17147982
[TBL] [Abstract][Full Text] [Related]
19. CNS-active drugs in aging population at high risk of cerebrovascular events: evidence from preclinical and clinical studies.
Zhao CS; Hartikainen S; Schallert T; Sivenius J; Jolkkonen J
Neurosci Biobehav Rev; 2008; 32(1):56-71. PubMed ID: 17599405
[TBL] [Abstract][Full Text] [Related]
20. ANAM genogram: historical perspectives, description, and current endeavors.
Reeves DL; Winter KP; Bleiberg J; Kane RL
Arch Clin Neuropsychol; 2007 Feb; 22 Suppl 1():S15-37. PubMed ID: 17276030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
